bf/NASDAQ:REVB_icon.jpeg

COM:REVBIOSCIENCES

Revelation Biosciences, Inc.

  • Stock

USD

Last Close

0.75

22/11 21:00

Market Cap

3.00M

Beta: -

Volume Today

116.70K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
cash per share
1.15
-
3.45
200.44%
9.75
182.73%
52.45
438.19%
company equity multiplier
-6.23
-
1.35
121.73%
-20.53
1,615.97%
5.23
125.47%
1.84
64.87%
days of inventory outstanding
days of payables outstanding
19.82K
-
days of sales outstanding
dividend yield
ebit per revenue
ebt per ebit
1.00
-
0.94
6.19%
1.00
6.98%
1.00
0.62%
0.01
98.61%
effective tax rate
0.00
-
-0.00
100.26%
enterprise value multiple
-24.39K
-
-10.54K
56.78%
-10.96
99.90%
0.15
101.40%
0.99
544.12%
fixed asset turnover
free cash flow per share
-0.05
-
-30.34
60,581.26%
-20.81
31.41%
-31.87
53.11%
gross profit margin
interest coverage
286.18
-
310.75
8.59%
inventory turnover
long term debt to capitalization
net income per ebt
1
-
1
0%
1
0%
1.00
0.32%
1
0.32%
net profit margin
operating cash flow per share
-0.05
-
-29.99
59,867.72%
-20.81
30.59%
-31.87
53.11%
operating profit margin
payables turnover
0.02
-
pretax profit margin
price fair value
-24.41K
-
450.94
101.85%
-1.33K
394.35%
3.41
100.26%
0.52
84.83%
receivables turnover
return on assets
-0.16
-
-0.03
81.60%
-5.87
19,781.24%
-1.96
66.58%
-0.01
99.50%
return on capital employed
1.00
-
-0.04
104.26%
120.14
281,818.56%
-10.32
108.59%
-1.30
87.39%
return on equity
1
-
-0.04
104.00%
120.51
301,493.44%
-10.26
108.51%
-0.02
99.82%
total debt to capitalization
-0.20
-

All numbers in USD (except ratios and percentages)